WEBULL
WebtradeDownload

UiPath Stock Gets Oracle Marketplace Listing For Test Cloud

Simply Wall St · 1d ago
  • UiPath announced that UiPath Test Cloud is now listed on Oracle Marketplace, offering agentic, AI-powered testing for Oracle Fusion Cloud Applications, Oracle E-Business Suite, PeopleSoft, Siebel, JD Edwards, and a wide range of connected enterprise, web, API, and mobile systems.
  • The listing places UiPath Test Cloud directly in a central catalog used by Oracle customers. This can lower adoption friction, embed UiPath more deeply into existing Oracle workflows, and influence how enterprises think about automating quality assurance across complex application estates.
  • We will look at how UiPath's investment narrative is affected by Test Cloud's Oracle Marketplace presence and potential customer access gains.

Scan beyond UiPath and this Oracle-focused catalyst by reviewing a handpicked set of automation and AI peers in our 92 robotics and automation stocks.

UiPath Investment Narrative Recap

To own UiPath, you need to believe that an end to end automation platform can keep deepening usage inside large enterprises even as IT budgets stay tight and decision cycles stretch. The Oracle Marketplace listing for Test Cloud fits that story by putting UiPath closer to where core business applications live, although the near term financial impact looks limited.

The more immediate swing factor still sits in deal timing, macro sensitive budgets, and the SaaS transition that management already flags as a growth headwind. FX pressure and cautious fiscal 2026 guidance remain key risks. The Oracle channel access helps the setup, but it does not remove those execution challenges.

The Oracle Marketplace move lines up most clearly with UiPath's wider push into agentic automation products such as Agent Builder and Agentic Orchestration. Investors are watching whether these tools increase platform stickiness and drive higher value automation deals rather than just adding another point solution.

Platform breadth also connects to catalysts around cloud ARR, which already sits above US$975 million, and to partnerships with groups like Microsoft and Deloitte. The Oracle listing reinforces that partner led distribution theme, which matters if UiPath wants to offset slower forecast revenue growth and the 2% SaaS related drag flagged for this year.

UiPath's narrative projects US$2.2b revenue and US$355.6 million earnings by 2029. That path assumes 8.1% yearly revenue growth and an earnings decline of US$6.3 million from US$361.9 million today.

Uncover why UiPath's fair value indicates a 21% potential upside to its current price, which could narrow quickly.

NYSE:PATH 1-Year Stock Price Chart
NYSE:PATH 1-Year Stock Price Chart

Exploring Other Perspectives

One alternate view focuses on UiPath’s profitability rather than revenue growth. The most cautious analysts were modeling earnings of about US$307.6 million by 2029, with margins drifting toward 14.4% and revenue nearer US$2.1b. Those figures came before this Oracle Marketplace news, so opinions may shift. It is worth comparing both narratives yourself.

Explore 4 other UiPath fair value estimates, including one that suggests it could be worth just $15.50!

Reach Your Own Conclusion

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

  • A great starting point for your UiPath research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • See our latest analysis for UiPath. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate UiPath's overall financial health at a glance.

Looking For More Investment Ideas Beyond UiPath?

If the UiPath story has you thinking about where else automation, software, and resilient cash generation could matter in your portfolio, it helps to cast a wider net using structured stock lists rather than headlines.

  • For investors who care most about valuation support and balance sheet quality, start with a curated 33 high quality undervalued stocks that already screens for fundamentals instead of hype.
  • If your priority is capital protection and steadier business profiles, focus on a 32 resilient stocks with low risk scores that filters for companies with stronger risk scores before you spend time on deep research.
  • When the goal is to uncover potential future leaders early, broaden your watchlist with a 20 high quality undiscovered gems that highlights lesser known businesses with solid underlying metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.